About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluation of TaiHao Breast Ultrasound Diagnosis Software

NCT04551105·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

TaiHao Medical Inc.

With

Columbia University
Taipei Veterans General Hospital, Taiwan
Virginia Polytechnic Institute and State University

Age

21–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

B-mode breast ultrasound image
Female, age 21 or older
Breast lesion images acquired before a biopsy or surgery - these images were retrospectively collected with histology report.
Non-biopsied benign lesions with negative follow-up for a minimum of 24 months
At least two orthogonal views of a lesion

You may not be if

Breast lesion images acquired after biopsy or surgery.
Any breast surgeries or interventional procedures in the 12 months prior to ultrasound imaging
Case demonstrating administrative or technical errors
Multiple lesions in one 2-D ultrasound image
Breast ultrasound images with Doppler, elastography, or other overlays present
Case with less than 2-year follow-up and without biopsy confirmation

The record

StatusCompleted

PhaseNo phase

Taking part16

StartedAug 2020

UpdatedNov 2, 2022

Conditions

Breast Cancer Breast Diseases

Where1

Arlington Innovation Center: Health Research - Virginia Tech
Arlington, Virginia, United States

Clareo Health | Evaluation of TaiHao Breast Ultrasound Diagnosis Software